| Model Number |
N/A |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/20/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
The customer reported an observation of a reactive (positive) advia centaur toxoplasma g (toxo g) result which was considered discordant relative to repeat testing when using reagent lot#296.An initial reactive result was obtained on a patient sample.The reactive result was reported to the physician, who questioned the result.The same sample was repeated on the original advia centaur xpt instrument and obtained a non-reactive (negative result).The non-reactive result was considered correct and issued on the corrected report to the physician.There are no known reports of delay, patient intervention, or adverse health consequences due to this event.
|
| |
|
Additional Manufacturer Narrative
|
|
A customer from outside the united states (ous) reported observation of a reactive (positive) advia centaur toxoplasma igg (toxo g) result which was discordant relative to repeat testing.Siemens is evaluating this issue.
|
| |
|
Additional Manufacturer Narrative
|
|
Mdr 1219913-2025-00122 was initially filed on 24-jun-2025.Additional information (27-jun-2025): siemens healthcare diagnostics has concluded the investigation of the event.A customer from outside the united states (ous) reported observation of a reactive (positive) advia centaur toxoplasma igg (toxo g) result, which was discordant relative to repeat testing.Siemens evaluated the instrument data and the information provided by the customer.Siemens reviewed the customer's calibration data and internal quality control (qc).Calibration was valid, and the qc recovered acceptably.Reagent issues were ruled out based on review of qc which showed recovery within acceptable ranges and no issues were reported with other patient samples.Siemens analyzed interpretation rates on advia centaur xp/xpt toxo g and atellica im toxo g for lot 296 and showed consistent rates across both systems.The customer¿s calculated specificity for lot 296 was 99.96% compared to 98.6% in the instructions for use (ifu).Based on the available information, the cause of the discordant result cannot be determined.A product problem has not been identified.The customer is operational, and the reported issue was resolved by routine troubleshooting.Note: in section h6, the codes for investigation findings and investigation conclusions have been updated.
|
| |
|
Search Alerts/Recalls
|